資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/32507
|
| 標題: | Cumulative use of therapeutic bladder anticholinergics and the risk of dementia in patients with lower urinary tract symptoms: a nationwide 12-year cohort study |
| 作者: | Wang, Yi-Chi
Chen, Yung-Liang
Huang, Chun-Che
Chung-Han Ho(何宗翰)
Huang, Yu-Tung
Wu, Ming-Ping
Ou, Ming-Jung
Yang, Chiu-Hsien
Chen, Ping-Jen |
| 貢獻者: | Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Family Med
Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Family Med
I Shou Univ, Coll Med, Dept Healthcare Adm
Chi Mei Med Ctr, Dept Med Res
Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm
Chang Gung Mem Hosp, Ctr Big Data Analyt & Stat
Chi Mei Fdn Hosp, Dept Obstet & Gynecol, Div Urogynecol
Fu Jan Catholic Univ, Coll Med, Dept Obstet & Gynecol
Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med
Kaohsiung Med Univ, Coll Med, Sch Med
UCL, Marie Curie Palliat Care Res Dept, Div Psychiat
Chi Mei Med Ctr, Palliat Care Ctr |
| 關鍵字: | Anticholinergics
Cohort study
Cumulative defined daily doses
Dementia
Lower urinary tract symptoms |
| 日期: | 2019 |
| 上傳時間: | 2020-07-29 13:47:49 (UTC+8) |
| 出版者: | BMC |
| 摘要: | Background: Studies have shown an association between lower urinary tract symptoms (LUTS) and an increased risk of dementia. Whether anticholinergic use contributes to the development of dementia in patients with LUTS remains unknown, especially in Asian populations. This study aims to investigate the association between anticholinergic use and dementia in patients with LUTS. Methods: This study included patients aged 50 years and over with newly diagnosed LUTS (January 2001 to December 2005), divided into four groups according to their cumulative defined daily doses (cDDDs) of anticholinergics: < 28 cDDDs, 28-84 cDDDs, 85-336 cDDDs, >= 337 cDDDs. Patients were followed up until dementia developed or until the end of 2012. Results: We recruited a total of 16,412 patients. The incidence of dementia was 10% in the < 28 cDDD group, 8.9% in the 28-84 cDDD group, 11.5% in the 85-336 cDDD group, and 14.4% in the >= 337 cDDD group (p =.005). In a Cox proportional hazards analysis, the adjusted hazard ratio of dementia was 1.15 (95% CI = 0.97-1.37) in the 85336 cDDD group, and 1.40 (95% CI = 1.12-1.75) in the >= 337 cDDD group after adjusting for covariates. Conclusions: Our study indicates that higher cumulative anticholinergic exposure is associated with an increase in the risk of incident dementia in patients with LUTS aged 50 years of age and over. Either using one anticholinergic agent or switching anticholinergic agents cumulatively increases this risk. Therapeutic risks and benefits of using anticholinergics in LUTS treatment should be clinically reviewed and weighed. |
| 關聯: | Bmc Geriatrics, v.19, n.1, pp.380 |
| 顯示於類別: | [醫務管理系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| 10.1186-s12877-019-1401-y.pdf | | 765Kb | Adobe PDF | 434 | 檢視/開啟 | | index.html | | 0Kb | HTML | 1505 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
